申请人:CADILA HEALTHCARE LTD
公开号:WO2012073256A1
公开(公告)日:2012-06-07
The present invention relates to pharmaceutically acceptable salts of rosuvastatin of Formula (II), (II) wherein B is an organic amine selected from lysine, arginine, triethanol amine, ethanolamine, choline, epolamine, meglumine and ethylenediamine and process for the preparation thereof.
本发明涉及公认为药用的
罗伐他汀的盐,其
化学式为(II),其中B为从赖
氨酸、精
氨酸、
三乙醇胺、
乙醇胺、
胆碱、依普拉明、甲
糠醇胺和
乙二胺中选择的有机胺,并提供了其制备方法。